Common Name |
Diloxanide
Description |
Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections. Although it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
Diloxanide furoateHMDB
2-FuramideMeSH
FuramideMeSH
2,2-dichloro-4'-Hydroxy-N-methylacetanilide 2-furoateMeSH
Entamide furoateMeSH
Chemical Formlia |
C14H11Cl2NO4
Average Molecliar Weight |
328.147
Monoisotopic Molecliar Weight |
327.006513259
IUPAC Name |
4-(2,2-dichloro-N-methylacetamido)phenyl furan-2-carboxylate
Traditional Name |
diloxanide
CAS Registry Number |
3736-81-0
SMILES |
CN(C(=O)C(Cl)Cl)C1=CC=C(OC(=O)C2=CC=CO2)C=C1
InChI Identifier |
InChI=1S/C14H11Cl2NO4/c1-17(13(18)12(15)16)9-4-6-10(7-5-9)21-14(19)11-3-2-8-20-11/h2-8,12H,1H3
InChI Key |
BDYYDXJSHYEDGB-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as phenol esters. These are aromatic compounds containing a benzene ring substituted by a hydroxyl group and an ester group.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Benzenoids
Sub Class |
Phenol esters
Direct Parent |
Phenol esters
Alternative Parents |
Furoic acid esters
Anilides
Phenoxy compounds
Tertiary carboxylic acid amides
Heteroaromatic compounds
Carboxylic acid esters
Oxacyclic compounds
Monocarboxylic acids and derivatives
Organopnictogen compounds
Organonitrogen compounds
Organochlorides
Organic oxides
Hydrocarbon derivatives
Carbonyl compounds
Alkyl chlorides
Substituents |
Phenol ester
Furoic acid ester
Anilide
Furoic acid or derivatives
Phenoxy compound
Monocyclic benzene moiety
Furan
Tertiary carboxylic acid amide
Heteroaromatic compound
Carboxamide group
Carboxylic acid ester
Organoheterocyclic compound
Oxacycle
Carboxylic acid derivative
Monocarboxylic acid or derivatives
Organic oxide
Organonitrogen compound
Organochloride
Organohalogen compound
Organooxygen compound
Organic oxygen compound
Alkyl halide
Organopnictogen compound
Alkyl chloride
Carbonyl group
Organic nitrogen compound
Hydrocarbon derivative
Aromatic heteromonocyclic compound
Molecliar Framework |
Aromatic heteromonocyclic compounds
External Descriptors |
phenols (CHEBI:4601 )
benzoate ester (CHEBI:4601 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Not Available
Application |
Pharmaceutical
Cellliar locations |
Membrane (predicted from logP)
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.038 mg/mLALOGPS
logP3.33ALOGPS
logP3.08ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)13.09ChemAxon
pKa (Strongest Basic)-4.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area59.75 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity78.21 m3·mol-1ChemAxon
Polarizability30.28 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
LC-MS/MS |
LC-MS/MS Spectrum – , positivesplash10-0002-9321100000-2db11dd84428f82ca90eView in MoNA
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Membrane (predicted from logP)
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB08792
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB08792
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB08792
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
18400
KEGG Compound ID |
C07637
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Diloxanide_furoate
NuGOwiki Link |
HMDB15684
Metagene Link |
HMDB15684
METLIN ID |
Not Available
PubChem Compound |
19529
PDB ID |
Not Available
ChEBI ID |
858744
Product: MI-774
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
- McAuley JB, Herwaldt BL, Stokes SL, Becher JA, Roberts JM, Michelson MK, Juranek DD: Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years experience in the United States. Clin Infect Dis. 1992 Sep;15(3):464-8. [PubMed:1520794 ]
|
PMID: 16797584